Latest Non-Redemption Agreements: GSR II Meteora
GSR II Meteora Acquisition Corp. (GSRM) Adds Non-Redemption Agreement
On May 22, GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) entered into additional voting and non-redemption agreements with unaffiliated third parties in exchange for such Non-Redeeming Stockholders agreeing to either not redeem or to reverse any previously submitted redemption request with respect to an aggregate of 1,200,000 shares of the Company’s Class A common stock.
In exchange for the foregoing commitments not to redeem such shares, the company has agreed to issue to the Non-Redeeming Stockholders an aggregate of 12,000 shares of Class A common stock. If the extension proposal is approved, the Non-Redeeming Stockholders will be entitled to receive up to 24,000 shares of Class A common stock.
Including the voting and non-redemption agreements the company entered into on May 18, stockholders of Class A common stock have agreed to either redeem or reverse any previously submitted redemption request with respect to an aggregate of 7,233,000 shares.
READ
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Heard on the Street: VinFast’s SPAC Backers Are Backing Out Even by the standards of electric-vehicle startups, the $40 billion market value of Vietnamese electric-vehicle startup VinFast is wild, following its combination with Black Spade last month....
Murphy Canyon (NASDAQ:MURF) announced this morning that it has closed its combination with Conduit Pharmaceuticals and its shares and warrants are expected to begin trading on the Nasdaq under the symbols “CDT” and “CDTTW” on September 25. The company also closed a purchase of $20 million in Murphy Canyon units at close, which is to...
Indie Semiconductor (NASDAQ:INDI), which merged with Thunder Bridge II in June 2021, announced this morning that it has launched an exchange offer to convert each outstanding warrant to 0.285 Class A shares in the company. At Indie’s last closing price of $6.22, this is $1.77 of value each, although the stock has been rising since...
Atlantic Coastal II (NASDAQ:ACAB) has entered into a definitive agreement to combine with drug developer Abpro at a valuation of $725 million. Woburn, Massachusetts-based Abpro is advancing a series of drug candidates to potentially treat COVID, cancer and diabetic blindness. The combined company is expected to trade on the Nasdaq once the deal is completed...
Graf Acquisition Corp. IV (NYSE:GFOR) announced that it adjourned Wednesday’s completion vote for its combination with NKGen Biotech without conducting any business and will reopen proceedings at 4:00 p.m., Eastern time, on September 25, 2023 Once again, the adjournment is being done to provide additional time to continue its efforts to obtain additional financing. This new...